Company
Actuate Therapeutics
We aim to give patients the opportunity to live longer and better. Learn more about our lead drug, elraglusib.
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Our lead drug, elraglusib, targets multiple molecular pathways in cancer, offering patients the opportunity to live longer and better.
Loading relationship preview